ARTICLE | Distillery Therapeutics
Neurology
January 3, 2019 1:48 PM UTC
Mouse studies suggest an FMR1 peptide could help treat fragile X syndrome. In a mouse model of fragile X syndrome, a 298-mer human FMR1 peptide containing the N-terminal domain normalized the action p...
BCIQ Company Profiles